Moxetumomab pasudotox and TobraDex ST ophthalmic
Determining the interaction of Moxetumomab pasudotox and TobraDex ST ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
Generic Name: dexamethasone / tobramycin ophthalmic
Brand name: Tobradex, Tobradex ST, Tobradex ST
Synonyms: TobraDex ST (ophthalmic), TobraDex ST
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-Tobradex Suspension
- Moxetumomab pasudotox-Tobramycin
- Moxetumomab pasudotox-Tobramycin (Oral Inhalation)
- Moxetumomab pasudotox-Tobramycin (Systemic)
- Moxetumomab pasudotox-Tobramycin and Dexamethasone
- Moxetumomab pasudotox-Tobramycin and Dexamethasone Eye Drops
- TobraDex ST ophthalmic-Moxetumomab Pasudotox-tdfk
- TobraDex ST ophthalmic-Moxetumomab pasudotox-tdfk Intravenous
- TobraDex ST ophthalmic-Moxifloxacin
- TobraDex ST ophthalmic-Moxifloxacin (Systemic)
- TobraDex ST ophthalmic-Moxifloxacin Hydrochloride
- TobraDex ST ophthalmic-Moxifloxacin Injection